This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Social Bookmarking   What's this?

Use With Caution

Arch Ophthalmol. 2001;119:576-578.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE REPORT by Klein et al¹ in this month's ARCHIVES, presenting further analyses of data from the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), raises interesting issues about the Early Treatment Diabetic Retinopathy Study² (ETDRS) retinopathy severity scale and its use in epidemiologic studies and clinical trials. After adding 2 steps in the mild nonproliferative range of the ETDRS retinopathy scale, the authors assessed whether a 1 or more or 2 or more step progression along the ETDRS retinopathy severity scale during a 4-year period is predictive of subsequent progression to proliferative retinopathy or clinically significant macular edema during the next 6 years. The results of the analyses of this well-designed and well-conducted population-based study, the WESDR, are displayed in Figure 3 of their article.¹ The data show that patients who had experienced a 1-step progression of retinopathy during the first 4 years of follow-up were 5.8 times more likely . . . [Full Text of this Article]

OUTCOME MEASUREMENT FOR CLINICAL TRIALS OF DIABETIC RETINOPATHY


DATA FROM THE DIABETES CONTROL AND COMPLICATIONS TRIAL


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

How Many Steps of Progression of Diabetic Retinopathy Are Meaningful?: The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Ronald Klein, Barbara E. K. Klein, and Scot E. Moss
Arch Ophthalmol. 2001;119(4):547-553.
ABSTRACT | FULL TEXT